Cumberland Pharmaceuticals (CPIX) Cost of Revenue (2016 - 2026)
Cumberland Pharmaceuticals' Cost of Revenue history spans 16 years, with the latest figure at $14.7 million for Q4 2025.
- On a quarterly basis, Cost of Revenue rose 18.2% to $14.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.1 million, a 12.19% increase, with the full-year FY2025 number at $19.1 million, up 12.19% from a year prior.
- Cost of Revenue hit $14.7 million in Q4 2025 for Cumberland Pharmaceuticals, up from $988760.0 in the prior quarter.
- Over the last five years, Cost of Revenue for CPIX hit a ceiling of $14.7 million in Q4 2025 and a floor of -$4.2 million in Q4 2022.
- Historically, Cost of Revenue has averaged $3.4 million across 5 years, with a median of $2.2 million in 2022.
- Biggest five-year swings in Cost of Revenue: plummeted 225.92% in 2022 and later skyrocketed 711.35% in 2024.
- Tracing CPIX's Cost of Revenue over 5 years: stood at $3.3 million in 2021, then plummeted by 225.92% to -$4.2 million in 2022, then skyrocketed by 136.75% to $1.5 million in 2023, then skyrocketed by 711.35% to $12.4 million in 2024, then increased by 18.2% to $14.7 million in 2025.
- Business Quant data shows Cost of Revenue for CPIX at $14.7 million in Q4 2025, $988760.0 in Q3 2025, and $2.0 million in Q2 2025.